Skip to main content Skip to section navigation Skip to footer
Partnering Careers
IMV Inc.
  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
  • DPX Delivery Platform
    • Overview
    • Scientific Materials
  • Pipeline
    • Overview
    • Maveropepimut-S
    • Expanded Access
  • News & Media
    • Press Releases
    • Events
    • Email Alerts
  • Investors
    • Overview
    • Press Releases
    • Events, Webcasts & Presentations
    • Financial Info
    • Stock Data
    • Filings
    • Governance
    • Contacts
    • FAQ
  • Contact
    • Get in Touch
    • Safety & Respect
  • CCAA Proceedings
  • Partnering
  • Careers

Press Releases

News & Media

News & Media

  • Press Releases
  • Events
  • Email Alerts
Aug 27, 2010 5:30pm EDT

Immunovaccine Announces 2010 Second Quarter Results

Jul 12, 2010 9:00am EDT

Immunovaccine Licenses Clinical Stage Cancer Vaccine from Merck KGaA

Jun 29, 2010 7:45am EDT

Immunovaccine Signs Agreement With Oncothyreon To Develop Cancer Vaccine

Jun 09, 2010 5:54am EDT

Immunovaccine Appoints Acting CFO

Jun 07, 2010 5:30pm EDT

Immunovaccine Announces the Departure of Its Chief Financial Officer

Jun 07, 2010 7:08am EDT

Immunovaccine Signs Agreement with Vaxil BioTherapeutics to Advance Potential Cancer Vaccine

May 17, 2010 8:47am EDT

Immunovaccine Appoints Paul Kirkconnell to Board

May 12, 2010 3:25pm EDT

Immunovaccine Announces 2010 First Quarter Results

Apr 22, 2010 5:49am EDT

Immunovaccine Signs Research Agreement with Dana-Farber Cancer Institute

Apr 19, 2010 5:49am EDT

Immunovaccine Announces 2009 Year End Results

  • Previous Pagearrow_back
  • Page 1…
  • Page 40
  • Page 41
  • Page 42
  • Page 43
  • Next Pagearrow_forward
rss_feed News RSS
  • Visit us on Twitter

    Twitter

  • Visit us on LinkedIn

    LinkedIn

  • Visit us on Youtube

    Youtube

© IMV Inc. All Rights Reserved.
Privacy Policy Terms of Use Sitemap Manage Cookie Preferences